Last reviewed · How we verify

NCT05760105

Awareness of Osteoporosis in Ankylosing Spondylosis Patients

Status unknown Last updated 23 May 2023
What this trial tests

trial testing Patient Participation Form in Osteoporosis in 400 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
1 June 2024
1 December 2024

Quick facts

Lead sponsorUskudar State Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date1 December 2023
Primary completion1 June 2024
Estimated completion1 December 2024

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar State Hospital

Who can join

Adults 18 to 90, any sex, with Osteoporosis or Osteoporosis Risk. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Ankylosing spondylitis patients are at increased risk for developing osteoporosis. Identifying whether multiple sclerosis patients have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in ankylosing spondylitis patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Patient Participation Form

Trials testing the same drug.

Other recruiting trials for Osteoporosis

Currently open trials in the same condition.

Other Uskudar State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing